Resting State Alpha Electroencephalographic Rhythms Are Differently Related to Aging in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2021
Historique:
pubmed: 22 6 2021
medline: 16 9 2021
entrez: 21 6 2021
Statut: ppublish

Résumé

In relaxed adults, staying in quiet wakefulness at eyes closed is related to the so-called resting state electroencephalographic (rsEEG) rhythms, showing the highest amplitude in posterior areas at alpha frequencies (8-13 Hz). Here we tested the hypothesis that age may affect rsEEG alpha (8-12 Hz) rhythms recorded in normal elderly (Nold) seniors and patients with mild cognitive impairment due to Alzheimer's disease (ADMCI). Clinical and rsEEG datasets in 63 ADMCI and 60 Nold individuals (matched for demography, education, and gender) were taken from an international archive. The rsEEG rhythms were investigated at individual delta, theta, and alpha frequency bands, as well as fixed beta (14-30 Hz) and gamma (30-40 Hz) bands. Each group was stratified into three subgroups based on age ranges (i.e., tertiles). As compared to the younger Nold subgroups, the older one showed greater reductions in the rsEEG alpha rhythms with major topographical effects in posterior regions. On the contrary, in relation to the younger ADMCI subgroups, the older one displayed a lesser reduction in those rhythms. Notably, the ADMCI subgroups pointed to similar cerebrospinal fluid AD diagnostic biomarkers, gray and white matter brain lesions revealed by neuroimaging, and clinical and neuropsychological scores. The present results suggest that age may represent a deranging factor for dominant rsEEG alpha rhythms in Nold seniors, while rsEEG alpha rhythms in ADMCI patients may be more affected by the disease variants related to earlier versus later onset of the AD.

Sections du résumé

BACKGROUND
In relaxed adults, staying in quiet wakefulness at eyes closed is related to the so-called resting state electroencephalographic (rsEEG) rhythms, showing the highest amplitude in posterior areas at alpha frequencies (8-13 Hz).
OBJECTIVE
Here we tested the hypothesis that age may affect rsEEG alpha (8-12 Hz) rhythms recorded in normal elderly (Nold) seniors and patients with mild cognitive impairment due to Alzheimer's disease (ADMCI).
METHODS
Clinical and rsEEG datasets in 63 ADMCI and 60 Nold individuals (matched for demography, education, and gender) were taken from an international archive. The rsEEG rhythms were investigated at individual delta, theta, and alpha frequency bands, as well as fixed beta (14-30 Hz) and gamma (30-40 Hz) bands. Each group was stratified into three subgroups based on age ranges (i.e., tertiles).
RESULTS
As compared to the younger Nold subgroups, the older one showed greater reductions in the rsEEG alpha rhythms with major topographical effects in posterior regions. On the contrary, in relation to the younger ADMCI subgroups, the older one displayed a lesser reduction in those rhythms. Notably, the ADMCI subgroups pointed to similar cerebrospinal fluid AD diagnostic biomarkers, gray and white matter brain lesions revealed by neuroimaging, and clinical and neuropsychological scores.
CONCLUSION
The present results suggest that age may represent a deranging factor for dominant rsEEG alpha rhythms in Nold seniors, while rsEEG alpha rhythms in ADMCI patients may be more affected by the disease variants related to earlier versus later onset of the AD.

Identifiants

pubmed: 34151788
pii: JAD201271
doi: 10.3233/JAD-201271
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1085-1114

Auteurs

Claudio Babiloni (C)

Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy.
San Raffaele of Cassino, Cassino (FR), Italy.

Raffaele Ferri (R)

Oasi Research Institute - IRCCS, Troina, Italy.

Giuseppe Noce (G)

IRCCS SDN, Napoli, Italy.

Roberta Lizio (R)

IRCCS SDN, Napoli, Italy.

Susanna Lopez (S)

Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy.

Ivan Lorenzo (I)

Oasi Research Institute - IRCCS, Troina, Italy.

Federico Tucci (F)

Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy.

Andrea Soricelli (A)

IRCCS SDN, Napoli, Italy.
Department of Motor Sciences and Healthiness, University of Naples Parthenope, Naples, Italy.

Flavio Nobili (F)

Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Dipartimento di Neuroscienze, Oftalmologia, Genetica, Riabilitazione e Scienze Materno-infantili (DiNOGMI), Università di Genova, Genova, Italy.

Dario Arnaldi (D)

Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Dipartimento di Neuroscienze, Oftalmologia, Genetica, Riabilitazione e Scienze Materno-infantili (DiNOGMI), Università di Genova, Genova, Italy.

Francesco Famà (F)

Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Francesco Orzi (F)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Carla Buttinelli (C)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Franco Giubilei (F)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Virginia Cipollini (V)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Moira Marizzoni (M)

Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

Bahar Güntekin (B)

Department of Biophysics, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
REMER, Clinical Electrophysiology, Neuroimaging and Neuromodulation Laboratory, Istanbul Medipol University, Istanbul, Turkey.

Tuba Aktürk (T)

REMER, Clinical Electrophysiology, Neuroimaging and Neuromodulation Laboratory, Istanbul Medipol University, Istanbul, Turkey.

Lutfu Hanoğlu (L)

Department of Neurology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.

Görsev Yener (G)

Izmir Biomedicine and Genome Center, Dokuz Eylul University Health Campus, Izmir, Turkey.
Department of Neurosciences, Institute of Health Sciences, Dokuz Eylul University, Izmir, Turkey.

Yağmur Özbek (Y)

Department of Neurosciences, Institute of Health Sciences, Dokuz Eylul University, Izmir, Turkey.

Fabrizio Stocchi (F)

Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy.

Laura Vacca (L)

Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy.

Giovanni B Frisoni (GB)

Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland.

Claudio Del Percio (C)

Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH